Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Discover cash back credit cards that do not charge annual fees. Start saving while earning rewards!
26,411 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Societe Generale's SG-FORGE is expanding its stablecoin program by placing EUR CoinVertible and USD CoinVertible on C...
Billionaire investor Michael Burry has lodged a new tesla short bet, intensifying the debate over Tesla’s robotics pu...
The Trump administration has paused more than $1 billion in Medicaid payments to California and Minnesota amid suspec...
Intuitive Machines has sparked a sharp turn in its stock without a major news release. This article breaks down why i...
As AI and HPC demand accelerates, investors are shifting away from Intel toward foundry and lithography peers. This p...
SanDisk surged roughly 3,700% in a year, but a broad market pullback and profit-taking have funds trimming positions ...
Alphabet has overtaken its peers to become the most profitable U.S. tech giant as AI and cloud demand drive stronger ...
A veteran market watcher warns that AI-powered competition is eroding monopoly profits, signaling a brutal reset for ...
Palantir’s stock has moved little over the past year despite strong revenue growth, reigniting a debate about michael...
AI jitters are turning discount chains and shampoo makers into the market’s hottest trade, upending traditional defen...
When a founder makes a bold move after a price drop, investors sit up and take notice. This article unpacks what a pu...